Well sort of. In the grade school play ground kind of way where you imitate someome or copy someone else without much experience. Or just for fun.
Or profit.
Because follow on biologics are no more copycats than my two children are copycats because they came from the same combinnation of DNA. You can't even say that about twins.
Needless to say, just by ignoring all the science and safety concerns and searing them into law doesn't make follow on biologics similar in structure, treatment or safety. It's just saying they do. Hell, in the Waxman bill you can even take the innovator's name. Why not just take over the company?
The propnents of a short cut to follow on products want to do testing...it's just that they want the testing to be unsuspecting doctors and patients who will not be told they are being put on an imitation until after the fact. Post market safety commitments? Why, that's just for start up biotech companies with no cash flow and only five years of market or data exclusivity... And by they way, forget about tracking safety if the killer takes on YOUR name.
Or profit.
Because follow on biologics are no more copycats than my two children are copycats because they came from the same combinnation of DNA. You can't even say that about twins.
Needless to say, just by ignoring all the science and safety concerns and searing them into law doesn't make follow on biologics similar in structure, treatment or safety. It's just saying they do. Hell, in the Waxman bill you can even take the innovator's name. Why not just take over the company?
The propnents of a short cut to follow on products want to do testing...it's just that they want the testing to be unsuspecting doctors and patients who will not be told they are being put on an imitation until after the fact. Post market safety commitments? Why, that's just for start up biotech companies with no cash flow and only five years of market or data exclusivity... And by they way, forget about tracking safety if the killer takes on YOUR name.
